1.
In this case study, I demonstrate that CHCs are present in the blood of one patient with choroidal melanoma, lung adenocarcinoma, and a neuroendocrine tumor of the lung. [...]
2023 | Scholarly project capstone (M.D.) |
2.
The breast tumor microenvironment is a complex ecosystem of epithelial, immune, endothelial, fibroblast and adipose cells. Cellular phenotypes and spatial localizations w [...]
2022 | Thesis |
3.
Our lab recently identified radiation responsive microRNAs (miRNA) in colorectal cancer (CRC). The most upregulated candidate, miRNA 451a, inhibited tumor cell proliferat [...]
2022 | Dissertation |
4.
Cancers are complex diseases that operate at multiple biological scales - from atom to organism - and the purview of cancer systems biology is to integrate information be [...]
2021 | Dissertation |
5.
As a part of the Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) precision medicine cancer trial, serial biopsies from cancer patients ar [...]
2021 | Abstract |
6.
7.
This cancer cell-intrinsic GOT2-PPARĪ“ axis promotes spatial restriction of both CD4+ and CD8+ T cells from the tumor microenvironment, and fosters the immune-suppressive [...]
2021 | Dissertation |
8.
The inability to develop an effective anti-tumor immune response plays a key role in cancer progression. Patients with a strong anti-tumor T cell response, indicated by i [...]
2016-09-01 | Thesis |
9.
The HER2+ subtype of breast cancer typically results from amplification of the proto-oncogene ERBB2, that causes overexpression of the mitogenic cell surface receptor kin [...]
2017 | Dissertation |
10.
Leukocytes recruited to and persistent within chronically inflamed tissues play critical roles in fostering neoplastic progression. Immunotherapies designed to reprogram [...]
2019 | Dissertation |